LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 74

Search options

  1. Article ; Online: Neurofibromatosis 1 French national guidelines based on an extensive literature review since 1966.

    Bergqvist, Christina / Servy, Amandine / Valeyrie-Allanore, Laurence / Ferkal, Salah / Combemale, Patrick / Wolkenstein, Pierre

    Orphanet journal of rare diseases

    2020  Volume 15, Issue 1, Page(s) 37

    Abstract: Neurofibromatosis type 1 is a relatively common genetic disease, with a prevalence ranging between 1/3000 and 1/6000 people worldwide. The disease affects multiple systems with cutaneous, neurologic, and orthopedic as major manifestations which lead to ... ...

    Abstract Neurofibromatosis type 1 is a relatively common genetic disease, with a prevalence ranging between 1/3000 and 1/6000 people worldwide. The disease affects multiple systems with cutaneous, neurologic, and orthopedic as major manifestations which lead to significant morbidity or mortality. Indeed, NF1 patients are at an increased risk of malignancy and have a life expectancy about 10-15 years shorter than the general population. The mainstay of management of NF1 is a patient-centered longitudinal care with age-specific monitoring of clinical manifestations, aiming at the early recognition and symptomatic treatment of complications as they occur. Protocole national de diagnostic et de soins (PNDS) are mandatory French clinical practice guidelines for rare diseases required by the French national plan for rare diseases. Their purpose is to provide health care professionals with guidance regarding the optimal diagnostic and therapeutic management of patients affected with a rare disease; and thus, harmonizing their management nationwide. PNDS are usually developed through a critical literature review and a multidisciplinary expert consensus. The purpose of this article is to present the French guidelines on NF1, making them even more available to the international medical community. We further dwelled on the emerging new evidence that might have therapeutic potential or a strong impact on NF1 management in the coming feature. Given the complexity of the disease, the management of children and adults with NF1 entails the full complement healthcare providers and communication among the various specialties.
    MeSH term(s) Adult ; Child ; Humans ; Neurofibromatosis 1/diagnosis ; Skin
    Language English
    Publishing date 2020-02-03
    Publishing country England
    Document type Journal Article
    ZDB-ID 2225857-7
    ISSN 1750-1172 ; 1750-1172
    ISSN (online) 1750-1172
    ISSN 1750-1172
    DOI 10.1186/s13023-020-1310-3
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Severe cutaneous adverse reactions to drugs.

    Duong, Tu Anh / Valeyrie-Allanore, Laurence / Wolkenstein, Pierre / Chosidow, Olivier

    Lancet (London, England)

    2017  Volume 390, Issue 10106, Page(s) 1996–2011

    Abstract: During the past decade, major advances have been made in the accurate diagnosis of severe cutaneous adverse reactions (SCARs) to drugs, management of their manifestations, and identification of their pathogenetic mechanisms and at-risk populations. Early ...

    Abstract During the past decade, major advances have been made in the accurate diagnosis of severe cutaneous adverse reactions (SCARs) to drugs, management of their manifestations, and identification of their pathogenetic mechanisms and at-risk populations. Early recognition and diagnosis of SCARs are key in the identification of culprit drugs. SCARS are potentially life threatening, and associated with various clinical patterns and morbidity during the acute stage of Stevens-Johnson syndrome and toxic epidermal necrolysis, drug reactions with eosinophilia and systemic symptoms, and acute generalised exanthematous pustulosis. Early drug withdrawal is mandatory in all SCARs. Physicians' knowledge is essential to the improvement of diagnosis and management, and in the limitation and prevention of long-term sequelae. This Seminar provides the tools to help physicians in their clinical approach and investigations of SCARs.
    MeSH term(s) Acute Generalized Exanthematous Pustulosis/diagnosis ; Acute Generalized Exanthematous Pustulosis/epidemiology ; Acute Generalized Exanthematous Pustulosis/etiology ; Diagnosis, Differential ; Drug Hypersensitivity Syndrome/diagnosis ; Drug Hypersensitivity Syndrome/epidemiology ; Drug Hypersensitivity Syndrome/etiology ; Drug-Related Side Effects and Adverse Reactions/diagnosis ; Drug-Related Side Effects and Adverse Reactions/epidemiology ; Drug-Related Side Effects and Adverse Reactions/etiology ; Female ; Humans ; Incidence ; Male ; Prognosis ; Risk Assessment ; Severity of Illness Index ; Stevens-Johnson Syndrome/diagnosis ; Stevens-Johnson Syndrome/epidemiology ; Stevens-Johnson Syndrome/etiology
    Language English
    Publishing date 2017-05-02
    Publishing country England
    Document type Journal Article ; Review
    ZDB-ID 3306-6
    ISSN 1474-547X ; 0023-7507 ; 0140-6736
    ISSN (online) 1474-547X
    ISSN 0023-7507 ; 0140-6736
    DOI 10.1016/S0140-6736(16)30378-6
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Unusual oral mucosa damage during telaprevir treatment of chronic hepatitis C.

    Isakov, Vasily / Morozov, Sergey / Valeyrie-Allanore, Laurence

    Hepatology (Baltimore, Md.)

    2014  Volume 59, Issue 3, Page(s) 1209–1210

    MeSH term(s) Adult ; Antiviral Agents/adverse effects ; Hepatitis C, Chronic/drug therapy ; Humans ; Male ; Mouth Diseases/chemically induced ; Mouth Diseases/pathology ; Mouth Mucosa/drug effects ; Mouth Mucosa/pathology ; Oligopeptides/adverse effects
    Chemical Substances Antiviral Agents ; Oligopeptides ; telaprevir (655M5O3W0U)
    Language English
    Publishing date 2014-03
    Publishing country United States
    Document type Case Reports ; Letter
    ZDB-ID 604603-4
    ISSN 1527-3350 ; 0270-9139
    ISSN (online) 1527-3350
    ISSN 0270-9139
    DOI 10.1002/hep.26546
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Skin Testing and Drug Provocation Tests in Epidermal Necrolysis: A French Experience.

    Roux, Camille / Ben Said, Benoit / Milpied, Brigitte / Bernier, Claire / Staumont-Sallé, Delphine / Dezoteux, Frédéric / Soria, Angèle / Barbaud, Annick / Valeyrie-Allanore, Laurence / Tétart, Florence / Bellon, Nathalia / Lebrun-Vignes, Bénédicte / Gener, Gwendeline / Paul, Muriel / Ingen-Housz-Oro, Saskia / Assier, Haudrey

    The journal of allergy and clinical immunology. In practice

    2022  Volume 10, Issue 12, Page(s) 3252–3261.e2

    Abstract: Background: There are limited data on the use of skin testing, other than patch testing, and challenges in the evaluation of epidermal necrolysis (EN), including Stevens-Johnson syndrome and toxic epidermal necrolysis.: Objective: To report a French ... ...

    Abstract Background: There are limited data on the use of skin testing, other than patch testing, and challenges in the evaluation of epidermal necrolysis (EN), including Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Objective: To report a French multicenter experience in skin testing and challenges in EN, and investigate the factors associated with tests' positivity.
    Methods: All patients who were evaluated by patch tests (PTs), skin prick tests, intradermal tests (IDTs), or drug provocation tests (DPTs) for EN between 2010 and 2020 were retrospectively included through 2 French drug reaction networks.
    Results: In total, 113 patients were included from 8 centers. Median (interquartile range) time from EN to hypersensitivity workup was 7.9 months (5.1-15 months). All patients had PTs, 17 (15%) had skin prick tests or IDTs with delayed readings and 32 (28.3%) had DPTs. One mild reaction occurred after a DPT. Overall, 22 patients (19.5%) had positive PTs, and the only factors associated with positivity were Algorithm of Drug Causality for Epidermal Necrolysis (ALDEN) score and drug class. Only 1 IDT was positive but considered irrelevant. The DPTs were never performed to prove responsibility of a highly suspected drug but were used to confirm current tolerance of needed medications.
    Conclusions: Allergological workup in EN, performed by specialists involved in EN, seems safe. Skin tests, although of limited sensitivity, can be helpful for considering the reintroduction of essential drugs according to a benefit-to-risk decision. We propose an algorithm for approaching hypersensitivity testing in patients with EN, to be adapted to each patient.
    Language English
    Publishing date 2022-07-20
    Publishing country United States
    Document type Journal Article
    ZDB-ID 2843237-X
    ISSN 2213-2201 ; 2213-2198
    ISSN (online) 2213-2201
    ISSN 2213-2198
    DOI 10.1016/j.jaip.2022.07.008
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Patch testing in non-immediate cutaneous adverse drug reactions: value of extemporaneous patch tests.

    Assier, Haudrey / Valeyrie-Allanore, Laurence / Gener, Gwendeline / Verlinde Carvalh, Muriel / Chosidow, Olivier / Wolkenstein, Pierre

    Contact dermatitis

    2017  Volume 77, Issue 5, Page(s) 297–302

    Abstract: Background: Patch testing following a standardized protocol is reliable for identifying the culprit drug in cutaneous adverse drug reactions (CADRs). However, these patch tests (PTs) require pharmaceutical material and staff, which are not always easily ...

    Abstract Background: Patch testing following a standardized protocol is reliable for identifying the culprit drug in cutaneous adverse drug reactions (CADRs). However, these patch tests (PTs) require pharmaceutical material and staff, which are not always easily available.
    Objectives: To evaluate an extemporaneous PT method in CADRs.
    Methods: We retrospectively analysed data for all patients referred to our department between March 2009 and June 2013 for patch testing after a non-immediate CADR. The patients who supplied their own suspected drugs were tested both with extemporaneous PTs and with conventional PTs. Extemporaneous PTs involved a nurse crushing and diluting the drug in pet. in a ratio of approximately one-third to two-thirds. Standardized PTs were performed according to guidelines, with commercial drugs diluted to 30% or with active ingredients diluted to 10%. We analysed the data for the two PT methods in terms of the number of positive test reactions, drugs tested, and type of CADR for patients in whom the two PT methods were used.
    Results: In total, 75 of 156 patients underwent the two PT procedures, including 91 double tests. Overall, 21 tests gave positive reactions with the two methods, and 69 other tests gave negative results with the two methods.
    Conclusion: Our series yielded results similar to those of published series concerning the types of CADR and the drugs responsible. Our results suggest that, for CADRs, if a patient supplies a suspected drug but if the pharmaceutical material and staff are not available for conventional PTs, extemporaneous PTs performed by the nurse with the commercial drug used by the patient can be useful and reliable.
    Language English
    Publishing date 2017-11
    Publishing country England
    Document type Journal Article
    ZDB-ID 193121-0
    ISSN 1600-0536 ; 0105-1873
    ISSN (online) 1600-0536
    ISSN 0105-1873
    DOI 10.1111/cod.12842
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article: Phacomatoses.

    Valeyrie-Allanore, Laurence / Wolkenstein, Pierre

    La Revue du praticien

    2008  Volume 58, Issue 7, Page(s) 717–724

    Abstract: Phacomatosis include a group of hereditary disorders mainly characterized by abnormalities of ectodermal origin. Among these diseases, we will more precisely put the stress on neurofibromatosis and tuberous sclerosis complex, which corresponds to ... ...

    Title translation Phacomatosis.
    Abstract Phacomatosis include a group of hereditary disorders mainly characterized by abnormalities of ectodermal origin. Among these diseases, we will more precisely put the stress on neurofibromatosis and tuberous sclerosis complex, which corresponds to autosomal dominant disorders, with well defined clinical presentation and pathophysiology. In the absence of curative treatment, these diseases require life-long multidisciplinary management, adapted to age leading to earlier diagnosis and treatment of complications.
    MeSH term(s) Humans ; Neurocutaneous Syndromes/diagnosis
    Language French
    Publishing date 2008-04-15
    Publishing country France
    Document type English Abstract ; Journal Article ; Review
    ZDB-ID 205365-2
    ISSN 2101-017X ; 0035-2640
    ISSN (online) 2101-017X
    ISSN 0035-2640
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Absence of Efficacy of Everolimus in Neurofibromatosis 1-Related Plexiform Neurofibromas: Results from a Phase 2a Trial.

    Zehou, Ouidad / Ferkal, Salah / Brugieres, Pierre / Barbarot, Sébastien / Bastuji-Garin, Sylvie / Combemale, Patrick / Valeyrie-Allanore, Laurence / Sbidian, Emilie / Wolkenstein, Pierre

    The Journal of investigative dermatology

    2018  Volume 139, Issue 3, Page(s) 718–720

    MeSH term(s) Adult ; Everolimus/therapeutic use ; Female ; Follow-Up Studies ; Humans ; Immunosuppressive Agents/therapeutic use ; Magnetic Resonance Imaging ; Male ; Neurofibroma, Plexiform/epidemiology ; Neurofibroma, Plexiform/therapy ; Neurofibromatosis 1/epidemiology ; Young Adult
    Chemical Substances Immunosuppressive Agents ; Everolimus (9HW64Q8G6G)
    Language English
    Publishing date 2018-10-16
    Publishing country United States
    Document type Clinical Trial ; Clinical Trial, Phase II ; Letter ; Research Support, Non-U.S. Gov't
    ZDB-ID 80136-7
    ISSN 1523-1747 ; 0022-202X
    ISSN (online) 1523-1747
    ISSN 0022-202X
    DOI 10.1016/j.jid.2018.09.016
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Neurofibromatosis 1 French national guidelines based on an extensive literature review since 1966

    Christina Bergqvist / Amandine Servy / Laurence Valeyrie-Allanore / Salah Ferkal / Patrick Combemale / Pierre Wolkenstein / NF France Network

    Orphanet Journal of Rare Diseases, Vol 15, Iss 1, Pp 1-

    2020  Volume 23

    Abstract: Abstract Neurofibromatosis type 1 is a relatively common genetic disease, with a prevalence ranging between 1/3000 and 1/6000 people worldwide. The disease affects multiple systems with cutaneous, neurologic, and orthopedic as major manifestations which ... ...

    Abstract Abstract Neurofibromatosis type 1 is a relatively common genetic disease, with a prevalence ranging between 1/3000 and 1/6000 people worldwide. The disease affects multiple systems with cutaneous, neurologic, and orthopedic as major manifestations which lead to significant morbidity or mortality. Indeed, NF1 patients are at an increased risk of malignancy and have a life expectancy about 10–15 years shorter than the general population. The mainstay of management of NF1 is a patient-centered longitudinal care with age-specific monitoring of clinical manifestations, aiming at the early recognition and symptomatic treatment of complications as they occur. Protocole national de diagnostic et de soins (PNDS) are mandatory French clinical practice guidelines for rare diseases required by the French national plan for rare diseases. Their purpose is to provide health care professionals with guidance regarding the optimal diagnostic and therapeutic management of patients affected with a rare disease; and thus, harmonizing their management nationwide. PNDS are usually developed through a critical literature review and a multidisciplinary expert consensus. The purpose of this article is to present the French guidelines on NF1, making them even more available to the international medical community. We further dwelled on the emerging new evidence that might have therapeutic potential or a strong impact on NF1 management in the coming feature. Given the complexity of the disease, the management of children and adults with NF1 entails the full complement healthcare providers and communication among the various specialties.
    Keywords Neurofibromatosis type 1 ; Guidelines ; Management ; Multidisciplinary ; Diagnosis ; Genetic counseling ; Medicine ; R
    Subject code 610
    Language English
    Publishing date 2020-02-01T00:00:00Z
    Publisher BMC
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  9. Article ; Online: Fatal toxic epidermal necrolysis in a patient on teriflunomide treatment for relapsing multiple sclerosis.

    Gerschenfeld, Gaspard / Servy, Amandine / Valeyrie-Allanore, Laurence / de Prost, Nicolas / Cecchini, Jérôme

    Multiple sclerosis (Houndmills, Basingstoke, England)

    2015  Volume 21, Issue 11, Page(s) 1476–1477

    Abstract: We report a case of toxic epidermal necrolysis in a 46-year-old woman on teriflunomide treatment. Such a severe adverse cutaneous drug reaction with this new therapy for relapsing forms of multiple sclerosis should be early recognized in order to ensure ... ...

    Abstract We report a case of toxic epidermal necrolysis in a 46-year-old woman on teriflunomide treatment. Such a severe adverse cutaneous drug reaction with this new therapy for relapsing forms of multiple sclerosis should be early recognized in order to ensure the rapid withdrawal of the drug.
    MeSH term(s) Crotonates/adverse effects ; Fatal Outcome ; Female ; Humans ; Middle Aged ; Multiple Sclerosis, Relapsing-Remitting/drug therapy ; Stevens-Johnson Syndrome/etiology ; Toluidines/adverse effects
    Chemical Substances Crotonates ; Toluidines ; teriflunomide (1C058IKG3B)
    Language English
    Publishing date 2015-10
    Publishing country England
    Document type Case Reports ; Journal Article
    ZDB-ID 1290669-4
    ISSN 1477-0970 ; 1352-4585
    ISSN (online) 1477-0970
    ISSN 1352-4585
    DOI 10.1177/1352458515596601
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article: Exanthèmes médicamenteux et toxidermies sévères Signes généraux et muqueux imposent l'arrêt immédiat du médicament.

    Bensaïd, Benoît / Valeyrie-Allanore, Laurence / Lebrun-Vignes, Bénédicte / Nicolas, Jean-François

    La Revue du praticien

    2015  Volume 65, Issue 7, Page(s) 981–985

    Abstract: Cutaneous adverse drug reactions (CADR) are delayed hypersensivities. Their clinical presentation and severity are very diverse ranging from the frequent and benign exanthemas to the rare but severe CADR involving deep organs in the case of drug reaction ...

    Title translation DRUG INDUCED EXANTHEMA AND SEVERE CUTANEOUS DRUG REACTIONS.
    Abstract Cutaneous adverse drug reactions (CADR) are delayed hypersensivities. Their clinical presentation and severity are very diverse ranging from the frequent and benign exanthemas to the rare but severe CADR involving deep organs in the case of drug reaction with eosinophilia and systemic symptoms (DRESS) or leading to skin bulla and epidermal detachment in toxic epidermal necrolysis. The main differential diagnoses are infections, especially viral ones, which could give clinical symptoms identical to those occurring in CADR.
    MeSH term(s) Diagnosis, Differential ; Drug Eruptions/diagnosis ; Drug Eruptions/etiology ; Drug Eruptions/pathology ; Drug Hypersensitivity Syndrome/diagnosis ; Drug Hypersensitivity Syndrome/etiology ; Drug Hypersensitivity Syndrome/pathology ; Exanthema/chemically induced ; Exanthema/diagnosis ; Exanthema/pathology ; Humans ; Hypersensitivity, Delayed/chemically induced ; Hypersensitivity, Delayed/diagnosis ; Hypersensitivity, Delayed/pathology ; Severity of Illness Index ; Stevens-Johnson Syndrome/diagnosis ; Stevens-Johnson Syndrome/etiology ; Stevens-Johnson Syndrome/pathology
    Language French
    Publishing date 2015-09
    Publishing country France
    Document type English Abstract ; Journal Article
    ZDB-ID 205365-2
    ISSN 2101-017X ; 0035-2640
    ISSN (online) 2101-017X
    ISSN 0035-2640
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top